Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbiopharmadive.com
BioPharma Dive - Latest News
Get the latest updates from BioPharma Dive - Latest News directly as they happen.
Follow now 126 followers
Latest posts
Last updated about 1 hour ago
Sodium channel blockers for pain: New opportunities after Vertex’s ‘watershed’ moment
about 1 hour ago
The success of Vertex's opioid alternative Journavax could aid a group of...
Sage to lay off most staff amid Supernus buyout
about 16 hours ago
The biotech, which agreed to be bought by Supernus after clinical and...
Moderna flu shot outperforms marketed vaccines in large late-stage trial
about 22 hours ago
The mRNA drug developer said it will begin discussing approval with the...
AbbVie to buy CAR-T developer Capstan in deal worth up to $2.1B
about 22 hours ago
The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an...
FDA takes major step to ease access to CAR-T therapy
4 days ago
The agency removed some onerous requirements for the complex cancer drugs and...
Biocryst sells Europe business; Peter Marks criticizes new FDA vaccine rules
4 days ago
Biocryst is offloading part of its business for $250 million. Meanwhile, the...
Supreme Court upholds ACA preventive services mandate
4 days ago
The high court preserved a key portion of the Affordable Care Act...
Congress should reconsider breaking up pharmacy benefit managers, experts say
4 days ago
Many popular proposals to reform the PBM industry are missing the forest...
RFK Jr.-appointed panel recommends flu shots be free of contested preservative
5 days ago
Thimerosal, targeted by activists who claim it’s linked to autism, shouldn't be...
Vor, with new CEO, changes course to target autoimmune disease
5 days ago
The biotech, which earlier this year laid off nearly all of its...
Acadia’s ‘very bullish’ sales forecast restores some confidence on Wall Street
5 days ago
The brain drug developer is now saying that its two marketed products...
Incyte replaces CEO Hoppenot with dealmaker Meury
5 days ago
Bill Meury, who shepherded Karuna and Anthos to multibillion-dollar buyouts, will take...